European urology oncology : Impact Factor & More
eISSN: 2588-9311pISSN: 2588-9311
Share this on:
Aims and Scope of European urology oncology
European Urology Oncology is the new sister journal to European Urology and European Urology Focus, and the first official publication of the EAU fully devoted to the study of genitourinary malignancies. Less
Key Metrics
CiteScore 
9.4
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q2Surgery
SNIP
2.02
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on European urology oncology
European urology oncology Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2018 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in European urology oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in European urology oncology
Living with a Prostate Cancer Patient: Real-world Evidence from the Europa Uomo Prostate Cancer Partners in Europe Research Study.
- 10 Jan 2026
- European urology oncology
Best Practice in Preoperative Surgical Planning for Robotic-assisted Radical Prostatectomy: A European Consensus Statement.
- 8 Jan 2026
- European urology oncology
Effects of Causal and Noncausal Components of Screening on Prostate Cancer Mortality: A Mediation Analysis from the Dutch, Finnish, and Swedish Centers of the European Randomized Study of Screening for Prostate Cancer.
- 7 Jan 2026
- European urology oncology
Re: Andrea Necchi, Félix Guerrero-Ramos, Paul L. Crispen, et al. Gemcitabine Intravesical System plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Patients with MIBC: Primary Analysis and Biomarker Results of SunRISe-4. J Clin Oncol. In press. https://doi.org/10.1200/JCO-25-02382.
- 3 Jan 2026
- European urology oncology
Re: Paramananthan Mariappan, Jasmin Hart-Brooke, Rebecca Sparks, Tanya Lord-McKenzie. Bladder EpiCheck Triggered Photodynamic Diagnosis Biopsies Detect High-grade Bladder Cancer Recurrences Missed by White Light Cystoscopy. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2025.11.007.
- 3 Jan 2026
- European urology oncology
Results of the Randomized Phase 3 AFU-GETUG-20 Trial Evaluating Adjuvant Leuprorelin Acetate After Radical Prostatectomy in Men with High-risk Localized Prostate Cancer.
- 3 Jan 2026
- European urology oncology
Living with a Prostate Cancer Patient: Real-world Evidence from the Europa Uomo Prostate Cancer Partners in Europe Research Study.
- 10 Jan 2026
- European urology oncology
Best Practice in Preoperative Surgical Planning for Robotic-assisted Radical Prostatectomy: A European Consensus Statement.
- 8 Jan 2026
- European urology oncology
Effects of Causal and Noncausal Components of Screening on Prostate Cancer Mortality: A Mediation Analysis from the Dutch, Finnish, and Swedish Centers of the European Randomized Study of Screening for Prostate Cancer.
- 7 Jan 2026
- European urology oncology
Re: Andrea Necchi, Félix Guerrero-Ramos, Paul L. Crispen, et al. Gemcitabine Intravesical System plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Patients with MIBC: Primary Analysis and Biomarker Results of SunRISe-4. J Clin Oncol. In press. https://doi.org/10.1200/JCO-25-02382.
- 3 Jan 2026
- European urology oncology
Re: Paramananthan Mariappan, Jasmin Hart-Brooke, Rebecca Sparks, Tanya Lord-McKenzie. Bladder EpiCheck Triggered Photodynamic Diagnosis Biopsies Detect High-grade Bladder Cancer Recurrences Missed by White Light Cystoscopy. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2025.11.007.
- 3 Jan 2026
- European urology oncology
Results of the Randomized Phase 3 AFU-GETUG-20 Trial Evaluating Adjuvant Leuprorelin Acetate After Radical Prostatectomy in Men with High-risk Localized Prostate Cancer.
- 3 Jan 2026
- European urology oncology
FAQs on European urology oncology
How long has European urology oncology been actively publishing? 
What is the publishing frequency of European urology oncology?
How many articles did European urology oncology publish last year?
What is the eISSN & pISSN for European urology oncology?
What is Citescore for European urology oncology?
What is SNIP score for European urology oncology?
What is the SJR for European urology oncology?
Who is the publisher of European urology oncology?
